About Biomedical Tissues
Biomedical Tissues is a company based in Nantes (France) founded in 2010 by Pierre Layrolle.. Biomedical Tissues has raised $566.05 thousand across 1 funding round from investors including ABAB, Pays de la Loire Participations and Le Mans Sarthe Investment. Biomedical Tissues offers products and services including Synthetic Dental Membrane. Biomedical Tissues operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Nantes, France
- Founders Pierre Layrolle
-
Sectors
HealthcareChemicals & Materials
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biomedical Tissues
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$566.05 K (USD)
in 1 rounds
-
Latest Funding Round
$566.05 K (USD), Series A
Sep 26, 2017
-
Investors
ABAB
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biomedical Tissues
Biomedical Tissues offers a comprehensive portfolio of products and services, including Synthetic Dental Membrane. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Membrane used for guided bone regeneration in dental and implant procedures.
Funding Insights of Biomedical Tissues
Biomedical Tissues has successfully raised a total of $566.05K through 1 strategic funding round. The most recent funding activity was a Series A round of $566.05 thousand completed in September 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $566,050
-
First Round
First Round
(26 Sep 2017)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2017 | Amount | Series A - Biomedical Tissues | Valuation | ABAB , Pays de la Loire Participations |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biomedical Tissues
Biomedical Tissues has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include ABAB, Pays de la Loire Participations and Le Mans Sarthe Investment. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Regional investment fund supporting businesses in Pays de la Loire, France.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biomedical Tissues
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Biomedical Tissues
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biomedical Tissues Comparisons
Competitors of Biomedical Tissues
Biomedical Tissues operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Biomedical Tissues
When was Biomedical Tissues founded?
Biomedical Tissues was founded in 2010 and raised its 1st funding round 7 years after it was founded.
Where is Biomedical Tissues located?
Biomedical Tissues is headquartered in Nantes, France. It is registered at Nantes, Pays De La Loire, France.
Who is the current CEO of Biomedical Tissues?
Valerie Dumay is the current CEO of Biomedical Tissues.
Is Biomedical Tissues a funded company?
Biomedical Tissues is a funded company, having raised a total of $566.05K across 1 funding round to date. The company's 1st funding round was a Series A of $566.05K, raised on Sep 26, 2017.
What does Biomedical Tissues do?
Biomedical Tissues was founded in 2010 and is based in Nantes, France. Operations focus on the biomedical sector, where 3D matrix microfiber tissue membranes are synthesized. The product, known as Tisseos, is designed to mimic human tissue structures and is fully biodegradable. Applications include guided bone regeneration and guided tissue regeneration procedures. Leadership includes co-founder Pierre Layrolle and CEO Valerie Dumay.
Who are the top competitors of Biomedical Tissues?
Biomedical Tissues's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does Biomedical Tissues offer?
Biomedical Tissues offers Synthetic Dental Membrane.
Who are Biomedical Tissues's investors?
Biomedical Tissues has 3 investors. Key investors include ABAB, Pays de la Loire Participations, and Le Mans Sarthe Investment.